Green Cross Cell’s Immune Cell-LC designated as orphan drug for brain tumor from FDA

Green Cross Cell(Duk-Joo Lee), a cell therapy company, announced on the 17^th that their ‘Immune Cell-LC’ was designated as orphan drug from the U.S. FDA on the 17^th.

Immune Cell-LC acquired approval as an anticancer drug for liver cancer from the Ministry of Food and Drug Safety in 2007 and has been manufactured and sold in Korea. This is the second time for a liver cancer drug to be designate...